Genfit

Therapeutics for cardiometabolic and neurodegenerative diseases.

placeLoos, Hauts De France, France calendar_todayFounded 1999 groups154 employees language genfit.com

Innovation

115 patent families (55 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 5,197 times.

YearFilings
20157
20168
201714
201823
201930
202029
202133
202237
202328
202429
202533
202613

Social engagement

Social engagement: 17.2K social following, 6 posts in the last 12 months — around the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Private equity250%

Recent activity

8 Jun 2026
Product launch
NASHnext®
27 May 2026
Event
EASL 2026 | ACLF insights event co-hosted with EF CLIF
Coming soon